Molecularly Tailored Therapy for Pancreas Cancer
NCT01888978
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
Gem-OX
DRUG:
Gem-5FU
DRUG:
Gem-Tax
DRUG:
Modified FOLFOX-6
DRUG:
Ox-Tax
DRUG:
FOLFIRI
DRUG:
Tax-Iri
Sponsor
Georgetown University